Performance improvement measures in achieving glycemic control in the acute brain injury population.
Glycemic control is becoming a standard practice in the intensive care environment because it has been shown to produce positive patient outcomes and benefits. A 14-bed neurointensive care unit initiated a strict glycemic protocol and evaluated the results over a 1-year period through a performance improvement initiative. Results indicated that tight glycemic control could be achieved safely by adhering to an evidence-based established protocol. The average blood glucose level for all patients was between 90 and 130 mg/dl by Day 2 after the implementation of the glycemic control protocol. The purpose of this article was to explain how a strict glycemic protocol was safely implemented. Further research is necessary to determine long-term benefits of glycemic control in the population with neurocritical illness.
Moyer
Megan T
MT
Department of Neurosurgery, Hospital of the University of Pennsylvania Medical Center, Philadelphia, PA, USA. megan.moyer@uphs.upenn.edu
D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D001930:Brain Injuries / Q000150:complications* / Q000401:mortality; D002985:Clinical Protocols / Q000592:standards*; D003422:Critical Care / Q000379:methods* / Q000592:standards; D016903:Drug Monitoring; D055317:Evidence-Based Practice; D019983:Guideline Adherence; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D007003:Hypoglycemia / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D015403:Nursing Evaluation Research; D009741:Nursing Staff, Hospital / Q000193:education / Q000592:standards; D017063:Outcome Assessment, Health Care; D010348:Patient Care Team; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies; D017751:Safety Management; D017749:Total Quality Management / Q000458:organization & administration*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin